|
ISO 11137-1:2006
|
Sterilization of health care products Radiation Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices |
|
ISO 14160:2011
|
Sterilization of health care products Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives Requirements for characterization, development, validation and routine control of a sterilization process for medical devices |
|
IEC 60068-2-27:2008
|
Environmental testing - Part 2-27: Tests - Test Ea and guidance: Shock |
|
MEDDEV 2.12-1 : REV 8 : 2013
|
GUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM |
|
EN 12006-2:1998+A1:2009
|
Non active surgical implants - Particular requirements for cardiac and vascular implants - Part 2: Vascular prostheses including cardiac valve conduits |
|
ISO 21534:2007
|
Non-active surgical implants Joint replacement implants Particular requirements |
|
ISO 5840:2005
|
Cardiovascular implants Cardiac valve prostheses |
|
ASTM F 2503 : 2013 : REDLINE
|
Standard Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment |
|
ISO 13485:2016
|
Medical devices Quality management systems Requirements for regulatory purposes |
|
ISO 14937:2009
|
Sterilization of health care products General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices |
|
IEC 60601-2-33:2010+AMD1:2013+AMD2:2015 CSV
|
Medical electrical equipment - Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis |
|
ISO 21536:2007
|
Non-active surgical implants — Joint replacement implants — Specific requirements for knee-joint replacement implants |
|
IEC 60068-2-31:2008
|
Environmental testing - Part 2-31: Tests - Test Ec: Rough handling shocks, primarily for equipment-type specimens |
|
ISO 22442-1:2015
|
Medical devices utilizing animal tissues and their derivatives Part 1: Application of risk management |
|
ISO 11135-1:2007
|
Sterilization of health care products Ethylene oxide Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices |
|
ISO/TR 14283:2004
|
Implants for surgery Fundamental principles |
|
ISO/IEC Guide 51:2014
|
Safety aspects Guidelines for their inclusion in standards |
|
ISO 14602:2010
|
Non-active surgical implants — Implants for osteosynthesis — Particular requirements |
|
ASTM F 2052 : 2015 : REDLINE
|
Standard Test Method for Measurement of Magnetically Induced Displacement Force on Medical Devices in the Magnetic Resonance Environment |
|
IEC 60068-2-47:2005
|
Environmental testing - Part 2-47: Test - Mounting of specimens for vibration, impact and similar dynamic tests |
|
ISO 16061:2015
|
Instrumentation for use in association with non-active surgical implants General requirements |
|
ISO 8601:2004
|
Data elements and interchange formats Information interchange Representation of dates and times |
|
ISO 13408-1:2008
|
Aseptic processing of health care products — Part 1: General requirements |
|
ASTM F 2213 : 2017 : REDLINE
|
Standard Test Method for Measurement of Magnetically Induced Torque on Medical Devices in the Magnetic Resonance Environment |
|
ISO 10993-7:2008
|
Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals |
|
ISO 11137-2:2013
|
Sterilization of health care products — Radiation — Part 2: Establishing the sterilization dose |
|
ISO 10993-1:2009
|
Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process |
|
ISO 22442-2:2015
|
Medical devices utilizing animal tissues and their derivatives Part 2: Controls on sourcing, collection and handling |
|
ISO 25539-3:2011
|
Cardiovascular implants Endovascular devices Part 3: Vena cava filters |
|
ISO 14155:2011
|
Clinical investigation of medical devices for human subjects Good clinical practice |
|
ISO 22442-3:2007
|
Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents |
|
ISO 7197:2006
|
Neurosurgical implants Sterile, single-use hydrocephalus shunts and components |
|
ISO 14971:2007
|
Medical devices Application of risk management to medical devices |
|
ISO 7000:2014
|
Graphical symbols for use on equipment Registered symbols |
|
ISO 11607-1:2006
|
Packaging for terminally sterilized medical devices Part 1: Requirements for materials, sterile barrier systems and packaging systems |
|
ISO 14607:2007
|
Non-active surgical implants Mammary implants Particular requirements |
|
ISO 17664:2017
|
Processing of health care products Information to be provided by the medical device manufacturer for the processing of medical devices |
|
ISO 12891-1:2015
|
Retrieval and analysis of surgical implants Part 1: Retrieval and handling |
|
ISO 21535:2007
|
Non-active surgical implants — Joint replacement implants — Specific requirements for hip-joint replacement implants |
|
ISO 17665-1:2006
|
Sterilization of health care products — Moist heat — Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices |
|
ISO 16429:2004
|
Implants for surgery — Measurements of open-circuit potential to assess corrosion behaviour of metallic implantable materials and medical devices over extended time periods |